Covered recipient · General Payments record
CANDACE PERCIFULL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,392.08
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $635.89 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $377.47 | 28 |
| Acerta Pharma LLC | $150.97 | 3 |
| Exact Sciences Corporation | $33.83 | 2 |
| Lilly USA, LLC | $20.92 | 1 |
| Teva Pharmaceuticals USA, Inc. | $20.38 | 1 |
| Neurocrine BioSciences, Inc. | $16.56 | 1 |
| PFIZER INC. | $15.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.21 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832816 | CMS |
| ABBVIE INC. | $8.85 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832818 | CMS |
| ABBVIE INC. | $32.03 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832820 | CMS |
| ABBVIE INC. | $11.93 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832822 | CMS |
| ABBVIE INC. | $31.56 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832824 | CMS |
| ABBVIE INC. | $16.94 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832826 | CMS |
| ABBVIE INC. | $6.63 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832828 | CMS |
| ABBVIE INC. | $8.81 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832830 | CMS |
| ABBVIE INC. | $7.09 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832832 | CMS |
| ABBVIE INC. | $23.56 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832834 | CMS |
| ABBVIE INC. | $9.02 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832836 | CMS |
| ABBVIE INC. | $9.73 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832838 | CMS |
| ABBVIE INC. | $5.35 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832840 | CMS |
| ABBVIE INC. | $7.50 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832842 | CMS |
| ABBVIE INC. | $3.77 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832844 | CMS |
| ABBVIE INC. | $8.09 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832846 | CMS |
| ABBVIE INC. | $29.03 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832848 | CMS |
| ABBVIE INC. | $9.88 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832850 | CMS |
| ABBVIE INC. | $12.29 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832852 | CMS |
| ABBVIE INC. | $9.65 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832854 | CMS |
| ABBVIE INC. | $34.96 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832856 | CMS |
| ABBVIE INC. | $26.66 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832858 | CMS |
| ABBVIE INC. | $8.64 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832860 | CMS |
| ABBVIE INC. | $8.58 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832862 | CMS |
| ABBVIE INC. | $4.71 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832864 | CMS |
| ABBVIE INC. | $6.28 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832866 | CMS |
| ABBVIE INC. | $9.44 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832868 | CMS |
| ABBVIE INC. | $18.28 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107832870 | CMS |
| AstraZeneca Pharmaceuticals LP | $11.14 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104330852 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.99 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105403934 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.84 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104507344 | CMS |
| Exact Sciences Corporation | $15.78 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114831086 | CMS |
| Exact Sciences Corporation | $18.05 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114831091 | CMS |
| Lilly USA, LLC | $20.92 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135613134 | CMS |
| Neurocrine Biosciences, Inc. | $16.56 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150996982 | CMS |
| PFIZER INC. | $15.76 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131141907 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.38 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151530245 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.